Ensign Peak Advisors’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7,000
Closed -$53K 1837
2022
Q3
$53K Sell
7,000
-6,100
-47% -$42.4K ﹤0.01% 2206
2022
Q2
$112K Hold
13,100
﹤0.01% 1939
2022
Q1
$296K Hold
13,100
﹤0.01% 1759
2021
Q4
$362K Hold
13,100
﹤0.01% 1745
2021
Q3
$365K Hold
13,100
﹤0.01% 1683
2021
Q2
$376K Buy
13,100
+1,600
+14% +$48.5K ﹤0.01% 1639
2021
Q1
$360K Hold
11,500
﹤0.01% 1648
2020
Q4
$238K Hold
11,500
﹤0.01% 1700
2020
Q3
$184K Sell
11,500
-3,800
-25% -$65.5K ﹤0.01% 1670
2020
Q2
$293K Hold
15,300
﹤0.01% 1539
2020
Q1
$257K Hold
15,300
﹤0.01% 1501
2019
Q4
$459K Buy
+15,300
New +$398K ﹤0.01% 1527

Other funds holding BHC

Ensign Peak Advisors's BHC Position: Q4 2022 in Review

Ensign Peak Advisors sold out of Bausch Health (BHC) in Q4 2022, closing a stake of 7,000 shares — an estimated $53K sold.

Ensign Peak Advisors first reported a position in BHC in Q4 2019 and held it in 12 quarters. The position peaked at $459K in Q4 2019. 262 funds tracked by Wall St. Rank hold BHC as of Q4 2022.

  • Ensign Peak Advisors reported no remaining Bausch Health position as of Q4 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 7,000 Bausch Health shares in Q4 2022, an estimated $53K.
  • Ensign Peak Advisors first reported a position in Bausch Health in Q4 2019 and held it in 12 quarters.
  • Ensign Peak Advisors's Bausch Health position peaked at $459K in Q4 2019.
  • 262 funds tracked by Wall St. Rank held Bausch Health as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.